From Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs:

msouza_cropped

msouza_cropped—

Photo of Praxis Precision Medicines CEO Marcio Souza. Photo by Praxis.

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

Sponsored · Whitepaper
How Big Is the US Market for Medical Devices & Technologies?
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!